California’s mental health crisis: What went wrong? And can we fix It?

California Gov. Gavin Newsom is steering a major transformation of California’s behavioral healthcare system, with much at stake in the years ahead. On Oct. 6, the Sacramento-based publication Capitol Weekly invited KHN’s Angela Hart to moderate an expert panel tackling the origins of the state’s broken system and potential solutions ahead.

The lively discussion featured healthcare leaders with deep experience in the political, provider and research aspects of mental health and addiction. The panelists were Dr. Elaine Batchlor, CEO of MLK Community Healthcare; former state Sen. Jim Beall, a Santa Clara County Democrat who spearheaded mental health legislation during his tenure in the legislature; Michelle Doty Cabrera, executive director of the County Behavioral Health Directors Association of California; and Janet Coffman, a researcher and faculty member with Healthforce Center at the University of California-San Francisco.

The discussion illuminated challenges that arise when the state puts insurance companies in charge of delivering critical health services, while also providing an overview of the ambitious policy changes the Newsom administration is pushing.

Click here to find a podcast of the full event. Hart hosts the first of three panels.

Kaiser Health News is a national health policy news service. It is an editorially independent program of the Henry J. Kaiser Family Foundation which is not affiliated with Kaiser Permanente.



Source link

Leave a Reply

Blog article

New omicron variant stokes world fears, triggers travel bans

The discovery of a new coronavirus variant sent a chill through much of the world Friday as nations raced to halt air travel, markets fell sharply and scientists held emergency meetings to weigh the exact risks, which were largely unknown. A World Health Organization panel named the variant “omicron” and classified it as a highly […]

Read More
Blog article

Merck COVID pill effective, experts will review safety

Federal health regulators say an experimental COVID-19 pill from Merck is effective against the virus, but they will seek input from outside experts on risks of birth defects and other potential problems during pregnancy. The Food and Drug Administration posted its analysis of the pill ahead of a public meeting next week where academic and […]

Read More
Blog article

Supreme Court to hear 340B case that could impact all hospitals

The Supreme Court will hear arguments in a case seeking to reverse cuts to the 340B Drug Program next week, and the outcome could have consequences for all providers, even those who don’t access the discounted medicines. Plaintiffs including the American Hospital Association and providers that participate in the program are asking the high court […]

Read More